Organovo Holdings, Inc. Price & Performance (ONVO)

Nio has reportedly undertaken layoffs across multiple teams, including its sales division, as part of cost-control measures. These changes follow disappointing sales performance of its sub-brand, Onvo, whose L60 model fell short of ambitious targets. Additionally, Nio has merged the store manager role at its flagship Nio Houses with sales positions to streamline operations.12

Organovo has raised $2.3 million through warrant exercises and stock sales, bolstering its financial position. This capital infusion is expected to support its ongoing development of treatments for inflammatory bowel disease. The move comes shortly after the company announced the sale of its FXR program to Eli Lilly, signaling strategic financial maneuvers.34

Onvo President Alan Ai has publicly addressed why the L60 SUV deliveries underperformed initial expectations. Ai cited insufficient preparation and mismanagement of customer benefits as key factors. He acknowledged lessons learned and emphasized plans to improve processes for future launches, while dismissing rumors of his resignation over missed targets.25